日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

MVI-targeted carbon-ion radiotherapy combined with immunotherapy for advanced hepatocellular carcinoma: Phase Ib DEPARTURE trial

针对晚期肝细胞癌的MVI靶向碳离子放射疗法联合免疫疗法:Ib期DEPARTURE试验

Ogasawara, Sadahisa; Koroki, Keisuke; Makishima, Hirokazu; Wakatsuki, Masaru; Takahashi, Asahi; Fujiya, Makoto; Yumita, Sae; Nakagawa, Miyuki; Kanzaki, Hiroaki; Kobayashi, Kazufumi; Inoue, Masanori; Nakamura, Masato; Kanogawa, Naoya; Kondo, Takayuki; Nakamoto, Shingo; Kurokawa, Tomoya; Ozawa, Yoshihito; Inaba, Yosuke; Paritala, Soumith; Chen, Jingxuan; Lee, Jeon; Hoshida, Yujin; Hanaoka, Hideki; Yamada, Shigeru; Ishikawa, Hitoshi

Durable Disease Control With Atezolizumab Plus Bevacizumab but Limited Post-Progression Outcomes: A Multicenter Real-World Study in Advanced Hepatocellular Carcinoma

阿特珠单抗联合贝伐珠单抗可实现持久的疾病控制,但疾病进展后的疗效有限:一项针对晚期肝细胞癌的多中心真实世界研究

Inoue, Masanori; Ogasawara, Sadahisa; Asahara, Kazuhisa; Sato, Rui; Watanabe, Shunji; Anzai, Haruka; Tsubura, Kazuo; Watabe, Taro; Fujiya, Makoto; Akatsuka, Teppei; Izai, Ryo; Katayama, Keiichi; Sawada, Midori; Tsuchiya, Takahiro; Miwa, Chihiro; Yoshino, Ryohei; Yonemoto, Takuya; Fujimoto, Kentaro; Unozawa, Hidemi; Yumita, Sae; Kanzaki, Hiroaki; Koroki, Keisuke; Kobayashi, Kazufumi; Nakamura, Masato; Kanogawa, Naoya; Nakamoto, Shingo; Yokoyama, Masayuki; Kato, Jun; Moriguchi, Michihisa; Aramaki, Takeshi; Morimoto, Naoki

Exploratory case series of conversion to carbon ion radiotherapy after systemic therapy in advanced hepatocellular carcinoma

晚期肝细胞癌全身治疗后转换为碳离子放射治疗的探索性病例系列研究

Anzai, Haruka; Miwa, Chihiro; Ogasawara, Sadahisa; Fujiya, Makoto; Kurosaki, Hiroki; Tsuchiya, Takahiro; Yoshino, Ryohei; Katayama, Keiichi; Sawada, Midori; Akatsuka, Teppei; Izai, Ryo; Yonemoto, Takuya; Yumita, Sae; Koroki, Keisuke; Inoue, Masanori; Nakamura, Masato; Kanogawa, Naoya; Nakamoto, Shingo; Makishima, Hirokazu; Shinoto, Makoto; Wakatsuki, Masaru; Yamada, Shigeru; Ishikawa, Hitoshi; Kato, Jun

Comprehensive Analysis of Radiologic Cancer-Free Status through Various Treatment Approaches in Advanced-Stage Hepatocellular Carcinoma

晚期肝细胞癌不同治疗方法下放射学无癌状态的综合分析

Koroki, Keisuke; Ogasawara, Sadahisa; Izai, Ryo; Yonemoto, Takuya; Akatsuka, Teppei; Miwa, Chihiro; Yumita, Sae; Inoue, Masanori; Kobayashi, Kazufumi; Kiyono, Soichiro; Nakamura, Masato; Kanogawa, Naoya; Kondo, Takayuki; Nakamoto, Shingo; Nakada, Shinichiro; Sakai, Nozomu; Yokoyama, Masayuki; Ohtsuka, Masayuki; Kato, Naoya

Assessment of Macrovascular Invasion in Advanced Hepatocellular Carcinoma: Clinical Implications and Treatment Outcomes with Systemic Therapy

晚期肝细胞癌大血管侵犯的评估:临床意义及全身治疗的疗效

Inoue, Masanori; Ogasawara, Sadahisa; Kobayashi, Kazufumi; Okubo, Tomomi; Itokawa, Norio; Obu, Masamichi; Fujimoto, Kentaro; Unozawa, Hidemi; Yumita, Sae; Fujiwara, Kisako; Nakagawa, Miyuki; Kanzaki, Hiroaki; Koroki, Keisuke; Kiyono, Soichiro; Nakamura, Masato; Kanogawa, Naoya; Kondo, Takayuki; Nakamoto, Shingo; Nagashima, Kengo; Itobayashi, Ei; Atsukawa, Masanori; Koma, Yoshihiro; Azemoto, Ryosaku; Kato, Naoya

Randomized phase II study comparing two doses of regorafenib in second-line treatment for advanced hepatocellular carcinoma

一项随机II期研究比较了两种剂量的瑞戈非尼在晚期肝细胞癌二线治疗中的疗效

Koroki, Keisuke; Ogasawara, Sadahisa; Yumita, Sae; Nakagawa, Miyuki; Kanzaki, Hiroaki; Kobayashi, Kazufumi; Inoue, Masanori; Nakamura, Masato; Kanogawa, Naoya; Kondo, Takayuki; Suzuki, Eiichiro; Ooka, Yoshihiko; Nakamoto, Shingo; Shiko, Yuki; Ozawa, Yoshihito; Inaba, Yosuke

The efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma in relation to tumor-infiltrating lymphocytes

阿特珠单抗联合贝伐珠单抗治疗晚期肝细胞癌的疗效与肿瘤浸润淋巴细胞的关系

Kanzaki, Hiroaki; Ishino, Takamasa; Ogasawara, Sadahisa; Tsuchiya, Takahiro; Fujiya, Makoto; Sawada, Midori; Izai, Ryo; Akatsuka, Teppei; Miwa, Chihiro; Yonemoto, Takuya; Yumita, Sae; Nakagawa, Miyuki; Kojima, Ryuta; Koroki, Keisuke; Inoue, Masanori; Kobayashi, Kazufumi; Kanogawa, Naoya; Nakamura, Masato; Kondo, Takayuki; Nakamoto, Shingo; Takayashiki, Tsukasa; Takano, Yuka; Takata, Kaho; Lin, Jason; Kawazu, Masahito; Ikeda, Jun-Ichiro; Ohtsuka, Masayuki; Hoshida, Yujin; Komuta, Mina; Togashi, Yosuke

Durvalumab Monotherapy in Complex Advanced Hepatocellular Carcinoma: A Real-World Study of Patients Ineligible for Combination Immunotherapy

度伐利尤单抗单药治疗复杂晚期肝细胞癌:一项针对不适合联合免疫疗法患者的真实世界研究

Miwa, Chihiro; Ogasawara, Sadahisa; Yonemoto, Takuya; Yumita, Sae; Okubo, Tomomi; Nakagawa, Miyuki; Koroki, Keisuke; Inoue, Masanori; Kanogawa, Naoya; Nakamura, Masato; Kondo, Takayuki; Nakamoto, Shingo; Itokawa, Norio; Atsukawa, Masanori; Itobayashi, Ei; Kato, Naoya

Incidence and Short-Term Prognosis of Acute-On-Chronic Liver Failure Defined by Japanese Criteria: A Single-Center Retrospective Cohort Study From Urban Japan

根据日本标准定义的急性加重型慢性肝衰竭的发生率和短期预后:一项来自日本城市的单中心回顾性队列研究

Kamezaki, Hidehiro; Iwanaga, Terunao; Maeda, Takahiro; Senoo, Junichi; Ogasawara, Sadahisa; Nakamoto, Shingo; Kato, Naoya

Clinical risk factors for portal hypertension-related complications in systemic therapy for hepatocellular carcinoma

肝细胞癌全身治疗中门静脉高压相关并发症的临床危险因素

Fujiwara, Kisako; Kondo, Takayuki; Fujimoto, Kentaro; Yumita, Sae; Ogawa, Keita; Ishino, Takamasa; Nakagawa, Miyuki; Iwanaga, Terunao; Tsuchiya, Satoshi; Koroki, Keisuke; Kanzaki, Hiroaki; Inoue, Masanori; Kobayashi, Kazufumi; Kiyono, Soichiro; Nakamura, Masato; Kanogawa, Naoya; Ogasawara, Sadahisa; Nakamoto, Shingo; Chiba, Tetsuhiro; Koizumi, Jun; Kato, Jun; Kato, Naoya